Human IgE (recombinant)
Recombinant human IgE antibody (hIgEλ), whose amino acid sequences are identical to the first-described IgE antibody from a myeloma patient with initials N.D.
The recombinant antibody is produced transiently under serum‐free conditions in optimized HEK293-cell system and purified through one-step purification with affinity chromatography.
In stock
Delivery time: 2-5 days
From: 331,00 € Excl. VAT and delivery costs
Please contact us for larger quantities.
Recombinant human IgE antibody (hIgEλ), whose amino acid sequences are identical to the
first-described IgE antibody from a myeloma patient with initials N.D, who was hospitalized in
1965. Thus, the antibody is also referred to as IgND or IgE (ND). From the blood of
patient N.D., a derived hIgEλ-producing myeloma cell line 266 BL or U-266 was developed.
The corresponding heavy and light chain sequences were determined and are published under
Genbank entries AH005278.2 and X51754, respectively.
The recombinant antibody is produced transiently under serum‐free conditions in optimized
HEK293-cell system and purified through one-step purification with affinity chromatography.
Product-ID: | RP_SZ_361 |
---|---|
Expression System: | Mammalian; HEK |
Isotype: | Human IgE |
Subclass: | hIgEλ2 |
Protein Accession #: | HC: AH005278.2 translation (residues 19–574) |
LC: X51754 translation (residues 20–235) | |
Formulation: | Liquid, PBS, pH 7.4, 0.2 μm sterile filtered |
Concentration: | ≥ 0.5 mg/ mL |
Purity: | ≥ 90 % (CGE, reducing conditions) |
< 5 % aggregates (Analytical SEC) |
The product is for research use or for further manufacturing only.
Additional information
Literature | [1] S. G. Johansson and H. Bennich, “Immunological studies of an atypical (myeloma) immunoglobulin.,” |
---|---|
Document | |
Notice | The product is for research use or for further manufacturing only. |
You must be logged in to post a review.
Reviews
There are no reviews yet.